AI assistant
Sending…
ORACLE CORP — Director's Dealing 2012
Dec 26, 2012
29742_dirs_2012-12-26_47580094-b791-4135-aac7-9dd84056a389.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2012-12-21
Reporting Person: Daley Dorian (SVP, Gen'l Counsel, Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-21 | Common Stock | M | 25000 | $20.75 | Acquired | 30000 | Direct |
| 2012-12-21 | Common Stock | M | 75000 | $20.73 | Acquired | 105000 | Direct |
| 2012-12-21 | Common Stock | S | 100000 | $33.5156 | Disposed | 5000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-21 | Stock Option | $20.75 | M | 25000 | Disposed | 2017-10-19 | Common Stock (25000) | Direct |
| 2012-12-21 | Stock Option | $20.73 | M | 75000 | Disposed | 2018-07-03 | Common Stock (75000) | Direct |
Footnotes
F1: Sale of shares pursuant to Rule 10b5-1 Plan adopted on April 26, 2012.
F2: This transaction was executed in multiple trades at prices ranging from $33.24 to $33.91. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Option vests 25% annually on anniversary of grant date.
More from ORACLE CORP
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 2